Skip to main content

GW&K Investment Management, LLC

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 1082917 BOSTON, MA

Position in RARE

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$33,843,174
+$2,208,813 QoQ
Shares Held
1,615,426
+17.5% QoQ
Ownership
1.64%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority Sole 96.38751859415498.ToString("F0")% Shared 3.5872249256698074.ToString("F0")% None 0.025256480175210642.ToString("F0")%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GW&K Investment Management, LLC holds $699,704,251 across 25 Biotechnology names. RARE ranks #9 (4.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RARE

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $33,843,174 1,615,426
2025-12-31 $31,634,361 1,375,407
2025-09-30 $34,597,082 1,150,169
2025-06-30 $17,499,631 481,288
2025-03-31 $18,185,060 502,211
2024-12-31 $21,436,558 509,545
2024-09-30 $25,917,907 466,569
2024-06-30 $16,707,930 406,519
2024-03-31 $14,164,672 303,377
2023-12-31 $14,706,036 307,529
2023-09-30 $11,084,119 310,915
2023-06-30 $13,214,907 286,471
2023-03-31 $2,538,891 63,314